SHARE BASED COMPENSATION - Schedule of RSUs to Services Providers and Advisers Outstanding (Details) - RSUs [Member] $ in Thousands |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
USD ($)
shares
| |
| SHARE BASED COMPENSATION - Schedule of RSUs to Services Providers and Advisers Outstanding (Details) [Line Items] | |
| Outstanding at beginning of year | 4,745,512 |
| Granted | 0 |
| Forfeited | (135,756) |
| Vested | (1,430,066) |
| Outstanding as of June 30, 2026 | 3,179,690 |
| Vested as of June 30, 2026 | 7,826,710 |
| Share-based payment expenses (in Dollars) | $ | $ 743 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Number of RSUs vested under share based payment. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|